| Literature DB >> 33841723 |
Carmen Alejandrina Virgen-Carrillo1, Alma Gabriela Martínez Moreno1, Juan José Rodríguez-Gudiño2, Jessica Elizabeth Pineda-Lozano1.
Abstract
BACKGROUND/Entities:
Keywords: Honey; feeding patterns; histology; rats; sucrose
Year: 2020 PMID: 33841723 PMCID: PMC8007410 DOI: 10.4162/nrp.2021.15.2.187
Source DB: PubMed Journal: Nutr Res Pract ISSN: 1976-1457 Impact factor: 1.926
Fluid, food, caloric intake and feed efficiency
| Characteristics | HS | SS | GFS |
|---|---|---|---|
| Fluid intake (mL) | 78.18 ± 4.23a | 46.47 ± 3.86b | 43.46 ± 3.89b |
| Food intake (g) | 9.85 ± 2.13a | 9.22 ± 1.71a | 10.51 ± 1.57a |
| Total caloric intake (kcal) | 126.85 ± 10.45a | 87.12 ± 7.51b | 87.37 ± 9.50b |
| Caloric intake from solutions1) (%) | 71.82 ± 3.72a | 63.91 ± 3.64b | 59.40 ± 2.52c |
| Feed efficiency (wg/total kcal) | 0.39 ± 0.04a | 0.26 ± 0.02b | 0.25 ± 0.02b |
HS, honey solution; SS, sucrose solution; GFS, glucose/fructose solution; wg, weight gain.
1)Respect to total caloric intake.
a-dMeans with different letters in a column were significantly different (P < 0.05) according to Tukey's test.
Fig. 1Behavioral patterns of (A) fluid, (B) food and (C) total caloric intake during 14 weeks.
HS, honey solution; SS, sucrose solution; GFS, glucose/fructose solution.
Biochemical analysis after 14 weeks of solutions consumption
| Characteristics | HS | SS | GFS |
|---|---|---|---|
| Glucose (mg/dL) | 110.7 ± 23.16NS | 119.75 ± 26.62 | 118.7 ± 26.04 |
| Insulin (μIU/mL) | 4.32 ± 4.07 | 4.87 ± 0.38 | 4.74 ± 0.47 |
| HOMA2-IR | 0.58 ± 0.54 | 0.67 ± 0.05 | 0.65 ± 0.05 |
| HOMA2-%B | 44.88 ± 26.95 | 43.68 ± 14.53 | 44.07 ± 15.69 |
| Leptin (pg/mL) | 555 ± 599 | 721 ± 507 | 549 ± 395 |
| TC (mg/100 mL) | 54.5 ± 7.33 | 48.87 ± 2.41 | 52.3 ± 8.61 |
| HDL-C (mg/100 mL) | 39.10 ± 9.44 | 36.25 ± 7.59 | 36.2 ± 5.99 |
| VLDL (mg/100 mL) | 20.44 ± 13.75 | 16.47 ± 6.55 | 22.92 ± 11.23 |
| Triglycerides (mg/100 mL) | 102.2 ± 68.79 | 82.37 ± 32.77 | 114.6 ± 56.19 |
| Atherogenic risk index (%) | 0.31 ± 0.47 | 0.31 ± 0.22 | 0.32 ± 0.15 |
HS, honey solution; SS, sucrose solution; GFS, glucose/fructose solution; HOMA2-IR, homeostatic model assessment for insulin resistance; HOMA2-%B, homeostatic model assessment β-cell function percent; TC, total cholesterol; HDL-C, high density lipoprotein-cholesterol; VLDL, very low density lipoprotein; NS, according to Tukey's test, no statistical significance was found among the groups in any variable.
Anthropometric measures and organ weights after 14 weeks of solutions consumption
| Characteristics | HS | SS | GFS |
|---|---|---|---|
| IBW | 76.32 ± 13.13NS | 77.21 ± 12.95 | 76.7 ± 13.52 |
| FBW | 407.6 ± 71.0 | 408.4 ± 39.0 | 431.6 ± 70.0 |
| Weight gain (FBW − IBW) | 331.2 ± 65.0 | 331.1 ± 40.0 | 354.9 ± 65.0 |
| Final abdominal circumference | 20.38 ± 1.02 | 20.50 ± 1.43 | 21.08 ± 1.25 |
| Final BMI | 0.77 ± 0.10 | 0.79 ± 0.06 | 0.80 ± 0.09 |
| Liver | 10.12 ± 2.38 | 10.42 ± 1.22 | 10.51 ± 2.12 |
| Pancreas | 1.11 ± 0.50 | 0.82 ± 0.20 | 1.26 ± 0.50 |
| Lungs | 2.22 ± 0.60 | 2.63 ± 0.20 | 2.29 ± 0.30 |
| Heart | 1.14 ± 0.10 | 1.19 ± 0.10 | 1.23 ± 0.20 |
| Kidneys | 2.70 ± 0.40 | 2.63 ± 0.30 | 2.70 ± 0.40 |
| Subcutaneous AT | 8.66 ± 9.30 | 10.61 ± 4.50 | 12.69 ± 9.80 |
| Visceral AT | 15.79 ± 10.10 | 18.7 ± 4.70 | 17.5 ± 8.8 |
| Epididymal AT | 2.22 ± 0.90 | 2.39 ± 0.70 | 2.91 ± 1.30 |
| Total AT | 26.6 ± 19.7 | 31.8 ± 8.3 | 33.12 ± 11.90 |
| Adiposity index | 6.11 ± 3.12 | 7.56 ± 1.89 | 7.60 ± 2.53 |
All data is expressed in grams.
HS, honey solution; SS, sucrose solution; GFS, glucose/fructose solution; IBW, initial body weight; FBW, final body weight; BMI, body mass index; AT, adipose tissue; NS, according to Tukey's test, no statistical significance was found among the groups in any variable.
Fig. 2Changes in (A) body weight and (B) body mass index along 14 weeks.
HS, honey solution; SS, sucrose solution; GFS, glucose/fructose solution.
Correlations with solutions intake
| Characteristics | Fluid intake (mL) | |||||
|---|---|---|---|---|---|---|
| HS | SS | GFS | ||||
| Weight gain (FBW − IBW) | 0.2431) | 0.147 | 0.3242) | 0.085 | 0.6723) | 0.003 |
| Total AT | 0.6033) | 0.065 | 0.6573) | 0.077 | 0.6603) | 0.038 |
| Adiposity index | 0.6173) | 0.058 | 0.6333) | 0.092 | 0.4092) | 0.241 |
| Glucose | 0.0931) | 0.799 | −0.1971) | 0.640 | −0.0601) | 0.870 |
| Insulin | 0.0001) | 0.999 | 0.1411) | 0.357 | 0.0021) | 0.889 |
| Leptin | 0.2291) | 0.161 | 0.3962) | 0.094 | 0.4822) | 0.025 |
| Total cholesterol | 0.2831) | 0.113 | 0.2571) | 0.199 | 0.0351) | 0.600 |
| Triglycerides | 0.5963) | 0.069 | −0.2761) | 0.509 | 0.6923) | 0.027 |
HS, honey solution; SS, sucrose solution; GFS, glucose/fructose solution; FBW, final body weight; IBW, initial body weight; AT, adipose tissue; r, Pearson's correlation coefficient; P, statistical significance.
1)Negligible correlation (0.00–0.30); 2)Low positive correlation (0.30–0.50); 3)Moderate positive correlation (0.50–0.70); values but with negative sign indicate the same level of correlation being negative [25].
Fig. 3Histology of liver tissue (hematoxylin and eosin stain, magnification at × 40). Blue arrow: microvacuoles with multivacuolated hepatocytes; green arrow: microvacuoles with univacuolated hepatocytes; orange arrow: macrovacuoles with univacuolated hepatocytes; pink arrow: hepatocellular necrosis; gray circle: portal triad; yellow circle: nuclear atypia.
HS, honey solution; SS, sucrose solution; GFS, glucose/fructose solution.